Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

MiR-155 expression level changes might be associated with initial phases of breast cancer pathogenesis and lymph-node metastasis.

Cancer biomarkers : section A of Disease markers - 1 Jan 2016

Petrović Nina, Kolaković Ana, Stanković Aleksandra, Lukić Silvana, Řami Ahmad, Ivković Maja, Mandušić Vesna

Abstract excerpt

BACKGROUND: Breast carcinoma is heterogeneous disease. Understanding the process of invasion and metastasis and the selection of the therapy for patients with breast carcinomas still remains difficult. MicroRNAs are powerful gene expression regulators. Because of inconsistent findings, we have analyzed potential difference in miR-155 levels in three breast cancer groups. OBJECTIVES: Our goals were to examine...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Biomarkers, Tumor
Share to Carcinogenesis

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to Carcinoma, Ductal, Breast

Share to Gene Expression Regulation, Neoplastic

Share to Lymph Nodes

Share to Lymphatic Metastasis

Share to MicroRNAs

Share to Neoplasm Invasiveness

Source

Open in PubMed Open full text

Identifiers

PMID: 26889816
DOI: 10.3233/CBM-160577
PMCID: PMC13016498

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 7 Sept 2026. Manifest publication-graph-cohort-2026-09-08.1.

Source receipt: pubmed, retrieved 7 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

MiR-155 expression level changes might be associated with initial phases of breast cancer pathogenesis and lymph-node metastasis.PMID 26889816Read ↗

Discovery and function exploration of microRNA-155 as a molecular biomarker for early detection of breast cancerSemantic proximity Read ↗

MicroRNA-155-5p promotes tumor progression and contributes paclitaxel resistance to chemotherapy via TP53INP1 in human Breast CancerSemantic proximity Read ↗

miR-155 downregulates ErbB2 and suppresses ErbB2-induced malignant transformation of breast epithelial cellsSemantic proximity Read ↗

Mutant p53 drives invasion in breast tumors through up-regulation of miR-155.Semantic proximity Read ↗

miR-155, identified as anti-metastatic by global miRNA profiling of a metastasis model, inhibits cancer cell extravasation and colonization in vivo and causes significant signaling alterations.Semantic proximity Read ↗

MicroRNA-155 functions as an OncomiR in breast cancer by targeting the suppressor of cytokine signaling 1 gene.Semantic proximity Read ↗

MicroRNA-155-5p Overexpression in Peripheral Blood Mononuclear Cells of Chronic Lymphocytic Leukemia Patients Is a Novel, Independent Molecular Biomarker of Poor PrognosisSemantic proximity Read ↗

MicroRNA-155 influences B-cell receptor signaling and associates with aggressive disease in chronic lymphocytic leukemiaSemantic proximity Read ↗

Transcriptional activation of the IGF-II/IGF-1R axis and inhibition of IGFBP-3 by miR-155 in hepatocellular carcinomaSemantic proximity Read ↗

[Expression and Prognostic Value of MiR-155 in Patients with Chronic Lymphocytic Leukemia].Semantic proximity Read ↗

MicroRNA-155 expression is independently predictive of outcome in chordomaSemantic proximity Read ↗

Inhibition of MiR-155 Using Exosomal Delivery of Antagomir Can Up-Regulate PTEN in Triple Negative Breast CancerSemantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.